Hilltop National Bank’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96K Hold
208
﹤0.01% 769
2026
Q1
$1.69K Hold
208
﹤0.01% 760
2025
Q4
$1.4K Hold
208
﹤0.01% 755
2025
Q3
$1.8K Hold
208
﹤0.01% 756
2025
Q2
$1.31K Buy
+208
New +$1.38K ﹤0.01% 763
2024
Q4
$281 Hold
35
﹤0.01% 769
2024
Q3
$442 Hold
35
﹤0.01% 801
2024
Q2
$443 Hold
35
﹤0.01% 808
2024
Q1
$167 Buy
+35
New +$162 ﹤0.01% 795

Other funds holding NVAX

Hilltop National Bank's NVAX Position: Q2 2026 in Review

Hilltop National Bank held its Novavax (NVAX) position steady in Q2 2026 at 208 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Hilltop National Bank first reported a position in NVAX in Q1 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Hilltop National Bank held 208 shares of Novavax worth $1.96K as of Q2 2026.
  • Hilltop National Bank left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Hilltop National Bank's portfolio in Q2 2026, its #769 holding.
  • Hilltop National Bank first reported a position in Novavax in Q1 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.